2023 Annual Profit: China Tobacco International (HK) Expects Significant Growth of More than 50%

Business by 2FIRSTS
Dec.20.2023
2023 Annual Profit: China Tobacco International (HK) Expects Significant Growth of More than 50%
China Tobacco International (HK) (06055.HK) announced positive profit expectations for 2023, with projected revenue and profit increases of at least 45% and 50% respectively.

On December 20th, China Tobacco Hong Kong (06055.HK) released its positive profit announcement for the full year of 2023. According to the announcement, it is expected that China Tobacco Hong Kong and its subsidiary companies (hereinafter referred to as the "Group") will record a revenue increase of no less than 45% for the annual period ending on December 31st, 2023, and a profit increase attributable to the company's owners of no less than 50%.

 

The announcement highlights three main factors contributing to the growth in the group's performance. Firstly, the delayed shipments of tobacco leaves due to the impact of the pandemic have gradually arrived throughout the year. Coupled with an increase in overall selling price compared to last year, this has led to growth in the group's revenue and gross profit from the importation of tobacco products this year. Secondly, the number of cross-border tourists has gradually increased as global pandemic control measures have been relaxed, leading to a significant growth in cigarette exports as consumption in the group's duty-free shops within the operating region has recovered. Additionally, the disruption in the shipping schedule has resulted in a substantial increase in sales of high-gross-margin tobacco by-products compared to the previous year, leading to significant growth in the group's revenue and gross profit from its operations in Brazil.

 

As the only tobacco-based company under China Tobacco Corporation, China Tobacco Hong Kong has always adhered to its strategic positioning as a "capital operation platform" and an "international business expansion platform". The group's performance has maintained steady and robust growth, with strong financial indicators and an increasing trend in dividend distribution. It is believed that the group will continue to actively seize market opportunities, adhere to the dual-drive development strategy of external expansion and internal growth, and create more value for shareholders in the future.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

"Lost Mary" Again Blocks Similar Trademark in the UK: “Love Mary” Found Likely to Cause Confusion
"Lost Mary" Again Blocks Similar Trademark in the UK: “Love Mary” Found Likely to Cause Confusion
The UK Intellectual Property Office has rejected Shenzhen Sendao Technology Co., Ltd.’s application to register the “Love Mary” trademark, siding with iMiracle (HK) Ltd., the owner of “Lost Mary.” The ruling determined that “Love Mary” was highly similar to “Lost Mary,” likely to mislead consumers, and risked damaging iMiracle’s established reputation and interests in the UK market.
Aug.21 by 2FIRSTS.ai
German tobacco industry leaders gathered at InterTabac to criticize the EU tax reform proposal: high taxes will kill the nicotine pouch industry and hurt fiscal revenue
German tobacco industry leaders gathered at InterTabac to criticize the EU tax reform proposal: high taxes will kill the nicotine pouch industry and hurt fiscal revenue
At the InterTabac opening press conference, German tobacco industry leaders criticized the EU’s proposed tax reform, warning that steep hikes could devastate the nicotine pouch sector, reduce excise revenue, and fuel illicit trade. They called on German policymakers to oppose the changes at the European level.
Sep.19
InterTabac 2025 Insights|Surge in Nicotine Pouch Brands: Higher Strengths & Category Diversification
InterTabac 2025 Insights|Surge in Nicotine Pouch Brands: Higher Strengths & Category Diversification
At InterTabac 2025, nicotine pouches emerged as one of the biggest highlights. Hall 6 was almost entirely taken over by pouch brands. Based on 2Firsts’ on-site observations, products commonly featured high nicotine strengths starting at 15 mg, with some reaching as high as 150 mg. Beyond nicotine pouches, exhibitors also rolled out caffeine/energy pouches, CBD pouches, and oral dissolvable films, while heavily emphasizing “Made in Sweden” as a market credential. Multiple OEM providers showcased
Sep.20 by 2FIRSTS.ai
Kennede Electronics MFG Co.,Ltd. 2025 Half-Year Report: E-cigarette Business Revenue Falls 54.57% to 26.21 million yuan, accounting for less than 5% of total revenue
Kennede Electronics MFG Co.,Ltd. 2025 Half-Year Report: E-cigarette Business Revenue Falls 54.57% to 26.21 million yuan, accounting for less than 5% of total revenue
In the first half of 2025, Kennede Electronics MFG Co.,Ltd. achieved an e-cigarette business revenue of 26.2068 million yuan, a year-on-year decrease of 54.57%, accounting for only 4.65% of the company’s total operating income, down from 7.26% in the same period of 2024. The company pointed out in its half-year report that the e-cigarette industry is facing overall export pressure due to the sudden drop in demand in the US market, stricter international tariffs and compliance policies.
Sep.01 by 2FIRSTS.ai
Malaysia's Perlis Customs seized more than 510,000 smuggled e-cigarettes, involving more than US$2.85 million
Malaysia's Perlis Customs seized more than 510,000 smuggled e-cigarettes, involving more than US$2.85 million
In August, Malaysia's Perlis Customs raided Kampung Kawlan, seizing 517,394 e-cig devices/accessories in a Padang Besar warehouse. Haul: over RM12m (≈US2.85m),unpaidtaxesRM2.6m(≈US620k); 19yo guard arrested. Probes: e-cigs for Thailand, arrived via KLIA, to cross border illegally (pickup/container truck or Kelantan if blocked). Case under 1967 Customs Act §133(1)(f): max RM500k (≈US$120k) fine/7yrs jail, or both.
Sep.22 by 2FIRSTS.ai
U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
U.S. Customs and Border Protection (CBP) seized approximately 165,000 illicit vaping products—including 90,000 e-cigarette devices and 75,000 refill cartridges—valued at over $1.47 million (MSRP). Following a joint assessment with the U.S. Food and Drug Administration (FDA), the products were deemed “adulterated and misbranded” for lacking required premarket authorization and were seized in accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act). The shipments, which featured multipl
Sep.30 by 2FIRSTS.ai